Resources search

Impact of transition to an individualised funding model on allied health support of participation opportunities

FOLEY, Kristen
ATTRILL, Stacie
MCALLISTER, Sue
BREBNER, Chris
February 2019

Expand view

Introduction: The National Disability Insurance Scheme is the new consumer-controlled funding system for people with disability in Australia, and is expected to enhance participation outcomes of people with disability. This research explored participation opportunities for people with disability during the formative period of transition to the scheme, through stakeholder accounts of changes in allied health service contexts.

 

Materials and methods: Qualitative data were generated during interviews, workshops and meetings with industry, policy, practice and education stakeholders involved in scheme services. Inductive coding explored key themes within the data. The International Classification of Functioning model was then applied as a deductive coding framework to illuminate how the scheme was perceived to be impacting participation opportunities for recipients of scheme funding.

 

Results and discussion: Using the International Classification of Functioning helped us illuminate whether changes resulting from scheme transition posed participation opportunities or barriers for scheme recipients. Research participants often framed these changes negatively, even when examples suggested that changes had removed participation barriers for scheme recipients. Some participants viewed changes as obstructing equitable and quality professional practice. We explore potential opportunities to resolve tensions that also optimise the participation outcomes of individuals who receive services through individualised funding.

Special issue on access to medicines, pricing and generics

September 2009

Expand view

This issue has articles about medicine prices in Vietnam, Thailand and South Africa, generic medicines in Malaysia and Australia, anti-retroviral therapy in South Africa, and legislation and regulation in the retail pharmacy sector in low-income countries.
Southern Med Review : Vol 2, Issue 2

Intellectual property rights and access to ARV medicines : civil society resistance in the global south|Brazil, Colombia, China, India, Thailand

REIS, Renata
TERTO, Veriano Jr
PIMENTA, Maria Cristina Pimenta
Eds
2009

Expand view

This book looks at "...the recent history and the many struggles related to advocacy for access to [antiretroviral] medicines of engaged civil society. Through the experiences of five middle-income countries - Brazil, China, Colombia, India, and Thailand." It presents "...the perspective of local civil society organisations about the national impact of intellectual property protection and access to medications. "These five countries were chosen due to their accumulated experience in this field, their capacity to produce generic medication, their activist efforts, and the exchange of ideas and information that already exists between them"

Successful leadership : country actions for maternal, newborn and child health

PARTNERSHIP FOR MATERNAL, NEWBORN AND CHILD HEALTH
2008

Expand view

This document provides country-specific summaries of actions taken on a national level to improve maternal and child health. The summaries do not provide a comprehensive assessment of the progress made by individual countries, but demonstrate the importance of five factors: 1. Successful political leadership (Thailand) 2. Sound health policies (Indonesia and Tanzania) 3. Effective financing (Mexico) 4. Strong health systems (Nepal and Senegal) 5. Action to achieve equity (Bangladesh and Chile). Each summary covers: progress on MDGs, supportive policies and interventions, outcome, and key lesson

IPR, innovation, human rights and access to drugs : an annotated bibliography

VELASQUEZ, Germán
VIDAL, Jaume
2003

Expand view

This annotated bibliography brings together references to scientific, legal and other materials on globalisation, patents and drugs. It is organised into sections on general articles (basic literature on the topic), country studies (by region), thematic sections on TRIPS (the World Trade Organization treaty on patents) and patents, drug research and development, and human rights and access to drugs. Finally a section on electronic information sources highlights useful websites and discussion groups on these issues. Each reference includes full bibliographic information and a thorough, descriptive abstract detailing the key points of each item

Effective drug regulation : a multicountry study

RATANAWIJITRASIN, Sauwakon
WONDEMAGEGNEHU, Eshetu
2002

Expand view

This publication presents a synthesis of studies on drug regulation carried out in ten countries: Australia, Cuba, Cyprus, Estonia, Malaysia, the Netherlands, Tunisia, Uganda, Venezuela, and Zimbabwe in 1998-1999. It gives an overview of the development of drug regulation in these countries as well as the resources available and the strategies applied in drug regulation implementation at the time the studies were conducted. An analysis of the strengths and weaknesses in drug regulation in these countries is also provided

Executive summary : globalisation and liberalisation of healthcare services. WTO and the General Agreement on Trade in Services

BALASUBRAMANIAM, K
2000

Expand view

This paper begins with a description of the evolution of the TRIPs Agreement. The TRIPs Agreement together with Trade Related Investment Measures (TRIMs) have taken away the powers of economic decision making from the national governments and handed them to the dominant actors in the international market place, namely the transnational corporations (TNCs). The international economic order has been radically restructured by the TRIPs Agreement which encompasses virtually the entire economic spectrum. To understand fully the implications of WTO/TRIPs Agreement on the access of drugs to consumers in the ASEAN region, this paper presents data on the pharmaceutical industry in the region and globally. All these countries have now changed their national legislation on patents in accordance with TRIPs Agreement. They will provide patent protection for pharmaceutical products. These countries will not be able to manufacture any drug under patent protection for a period of 20 years, resulting in the multinational drug companies having a monopoly of all patent protected drugs, leading to the collapse of the pharmaceutical industry in developing countries. The paper concludes that the only way to avoid this and strengthen the pharmaceutical sector in developing countries is through compulsory licensing and parallel imports, which are allowed in the TRIPs Agreement. This will enable consumers in the ASEAN countries to access affordable pharmaceuticals. This, consumers believe, is a short-term solution. The paper also gives a longterm solution, involving a shake up of the international governance system

Primary health care meets the market : lessons from China and Vietnam

BLOOM, Gerald
March 1997

Expand view

This paper outlines some lessons that policy makers can learn from China and Vietnam. Both countries developed low cost rural health services during the period between the early 1950s and the mid-1970s. Their example strongly influenced international health policy, and lessons from these case studies will have relevance to policy-makers in other low and middle income countries who are asking fundamental questions about how services should be financed, the relationship between service providers and government, and the role of the state in ensuring that health services are cost-effective and equitable [Author's abstact, adapted]

Programme report 1996

WORLD HEALTH ORGANIZATION (WHO). Global Programme for Vaccines and Immunization
1997

E-bulletin